These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27040726)

  • 1. Exposure Matching for Extrapolation of Efficacy in Pediatric Drug Development.
    Mulugeta Y; Barrett JS; Nelson R; Eshete AT; Mushtaq A; Yao L; Glasgow N; Mulberg AE; Gonzalez D; Green D; Florian J; Krudys K; Seo S; Kim I; Chilukuri D; Burckart GJ
    J Clin Pharmacol; 2016 Nov; 56(11):1326-1334. PubMed ID: 27040726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure Matching of Pediatric Anti-infective Drugs: Review of Drugs Submitted to the Food and Drug Administration for Pediatric Approval.
    Zimmerman K; Putera M; Hornik CP; Brian Smith P; Benjamin DK; Mulugeta Y; Burckart GJ; Cohen-Wolkowiez M; Gonzalez D
    Clin Ther; 2016 Sep; 38(9):1995-2005. PubMed ID: 27364807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.
    Mehrotra N; Bhattaram A; Earp JC; Florian J; Krudys K; Lee JE; Lee JY; Liu J; Mulugeta Y; Yu J; Zhao P; Sinha V
    Drug Metab Dispos; 2016 Jul; 44(7):924-33. PubMed ID: 27079249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrapolation of adult data and other data in pediatric drug-development programs.
    Dunne J; Rodriguez WJ; Murphy MD; Beasley BN; Burckart GJ; Filie JD; Lewis LL; Sachs HC; Sheridan PH; Starke P; Yao LP
    Pediatrics; 2011 Nov; 128(5):e1242-9. PubMed ID: 22025597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure-Response Assessment in Pediatric Drug Development Studies Submitted to the US Food and Drug Administration.
    Zhang Y; Wang Y; Khurana M; Sachs HC; Zhu H; Burckart GJ; Alexander J; Yao LP; Wang J
    Clin Pharmacol Ther; 2020 Jul; 108(1):90-98. PubMed ID: 32030741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent dosing and labeling since the Food and Drug Administration Amendments Act of 2007.
    Momper JD; Mulugeta Y; Green DJ; Karesh A; Krudys KM; Sachs HC; Yao LP; Burckart GJ
    JAMA Pediatr; 2013 Oct; 167(10):926-32. PubMed ID: 23921678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Extrapolation Approach for U.S. Food and Drug Administration Approval of Brexpiprazole in Patients Aged 13 to 17 Years with Schizophrenia.
    Zhang H; Liu J; Sharma V; Zhuang L; Horn P; Uppoor R; Mehta M; Zhu H
    J Clin Pharmacol; 2024 Jul; 64(7):771-778. PubMed ID: 38488344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allometry Is a Reasonable Choice in Pediatric Drug Development.
    Liu T; Ghafoori P; Gobburu JV
    J Clin Pharmacol; 2017 Apr; 57(4):469-475. PubMed ID: 27649629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steps toward harmonization for clinical development of medicines in pediatric ulcerative colitis-a global scientific discussion, part 2: data extrapolation, trial design, and pharmacokinetics.
    Sun H; Vesely R; Nelson RM; Taminiau J; Szitanyi P; Isaac M; Klein A; Uzu S; Griebel D; Mulberg AE;
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):684-8. PubMed ID: 24866782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failed Pediatric Drug Development Trials.
    Momper JD; Mulugeta Y; Burckart GJ
    Clin Pharmacol Ther; 2015 Sep; 98(3):245-51. PubMed ID: 25963725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric dosing for locally acting drugs in submissions to the U.S. Food and Drug Administration between 2002 and 2020.
    Abulwerdi GA; Ramamoorthy A; Bashaw E; Burckart GJ; Madabushi R; Fletcher EP
    Clin Transl Sci; 2023 Oct; 16(10):2046-2057. PubMed ID: 37551830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development.
    Wang J; Avant D; Green D; Seo S; Fisher J; Mulberg AE; McCune SK; Burckart GJ
    Clin Pharmacol Ther; 2015 Sep; 98(3):328-35. PubMed ID: 25975723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapolation of Efficacy from Adults to Pediatric Patients of Drugs for Treatment of Partial Onset Seizures: A Regulatory Perspective.
    Mehrotra S; Bhattaram A; Krudys K; Bewernitz M; Uppoor R; Mehta M; Liu T; Sheridan P; Hershkowitz N; Kozauer N; Bastings E; Dunn B; Men AY
    Clin Pharmacol Ther; 2022 Oct; 112(4):853-863. PubMed ID: 35678047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model-based approach to dose selection in early pediatric development.
    Cella M; Gorter de Vries F; Burger D; Danhof M; Della Pasqua O
    Clin Pharmacol Ther; 2010 Mar; 87(3):294-302. PubMed ID: 20107435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Efficacy Extrapolation in Drug Development Submitted to the US Food and Drug Administration 2015-2020.
    Samuels S; Park K; Bhatt-Mehta V; Sun H; Mulugeta Y; Yao L; Green DJ; Burckart GJ
    J Clin Pharmacol; 2023 Mar; 63(3):307-313. PubMed ID: 36150423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods Used for Pediatric Dose Selection in Drug Development Programs Submitted to the US FDA 2012-2020.
    Green FG; Park K; Burckart GJ
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S28-S35. PubMed ID: 34185898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving pediatric dosing through pediatric initiatives: what we have learned.
    Rodriguez W; Selen A; Avant D; Chaurasia C; Crescenzi T; Gieser G; Di Giacinto J; Huang SM; Lee P; Mathis L; Murphy D; Murphy S; Roberts R; Sachs HC; Suarez S; Tandon V; Uppoor RS
    Pediatrics; 2008 Mar; 121(3):530-9. PubMed ID: 18310202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gaps in Drug Dosing for Obese Children: A Systematic Review of Commonly Prescribed Emergency Care Medications.
    Rowe S; Siegel D; Benjamin DK;
    Clin Ther; 2015 Sep; 37(9):1924-32. PubMed ID: 26323523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging Adult Experience to Pediatrics in Oncology Drug Development.
    Leong R; Zhao H; Reaman G; Liu Q; Wang Y; Stewart CF; Burckart G
    J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S129-S135. PubMed ID: 28921643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Children in clinical trials: towards evidence-based pediatric pharmacotherapy using pharmacokinetic-pharmacodynamic modeling.
    Brussee JM; Calvier EA; Krekels EH; Välitalo PA; Tibboel D; Allegaert K; Knibbe CA
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1235-44. PubMed ID: 27269200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.